Lisata Therapeutics, Inc. (8NE.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 01:30PM CEST
| Previous close | 2.4800 |
| Open | 2.4800 |
| Bid | 2.5800 x N/A |
| Ask | 2.8200 x N/A |
| Day's range | 2.4800 - 2.4800 |
| 52-week range | 1.7400 - 4.0400 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 21.252M |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Lisata's (LSTA) LSTA1 Gets FDA Orphan Drug Tag for Osteosarcoma
The FDA bestows an Orphan Drug designation to Lisata's (LSTA) lead investigational product candidate, LSTA1, for the treatment of osteosarcoma. Stock rises.
- Zacks
Lisata's (LSTA) LSTA1 Gets FDA's RPDD Tag for Osteosarcoma
Lisata's (LSTA) lead investigational product candidate, LSTA1, gets Rare Pediatric Disease Designation for treating osteosarcoma. Stock rises.
- Simply Wall St.
Here's Why We're Watching Lisata Therapeutics' (NASDAQ:LSTA) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, although...
© 2024 Yahoo. All rights reserved.